Article Versions Notes

Yanagimoto H, Satoi S, Yamamoto T, Yamaki S, Hirooka S, Kotsuka M, Ryota H, Ishida M, Matsui Y, Sekimoto M. Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma. Cancers. 2020; 12(6):1428. https://doi.org/10.3390/cancers12061428

Yanagimoto, Hiroaki, Sohei Satoi, Tomohisa Yamamoto, So Yamaki, Satoshi Hirooka, Masaya Kotsuka, Hironori Ryota, Mitsuaki Ishida, Yoichi Matsui, and Mitsugu Sekimoto. 2020. "Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma" Cancers 12, no. 6: 1428. https://doi.org/10.3390/cancers12061428

Yanagimoto, H., Satoi, S., Yamamoto, T., Yamaki, S., Hirooka, S., Kotsuka, M., Ryota, H., Ishida, M., Matsui, Y., & Sekimoto, M. (2020). Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma. Cancers, 12(6), 1428. https://doi.org/10.3390/cancers12061428